[Chemotherapy of cancers of the larynx and hypopharynx].
D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005978:Glutathione / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007822:Laryngeal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D007825:Laryngectomy; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D010610:Pharyngeal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D011182:Postoperative Care; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use
D000614:Aminocaproates; D000970:Antineoplastic Agents; D001761:Bleomycin; D014747:Vinblastine; D003520:Cyclophosphamide; D005978:Glutathione; D008727:Methotrexate
La chimiothérapie dans les cancers du larynx et de l'hypopharynx.